Proceedings of the National Academy of Sciences · 1990 · 132 citations · 25 references
MedicineBiochemistryPharmacologyIon Channel BiophysicsMolecular PharmacologyNeuropharmacologyCellular Drug EffluxIon Channel PharmacologyIon Channel PhysiologyIon Channel RegulationIon ChannelsPotassium Channel BiophysicsAntidiabetic ActivityPotassium Channel BlockadePotassium Channel BlockersPotassium Channel FunctionPotassium Channel GatingPotassium Channel OpenersPotassium Channel PharmacologySubstantia Nigra Physiology
Vascular K+ channel openers such as cromakalim, nicorandil, and pinacidil potently stimulate 86Rb+ efflux from slices of substantia nigra. This 86Rb+ efflux is blocked by antidiabetic sulfonylureas, which are known to be potent and specific blockers of ATP-regulated K+ channels in pancreatic beta cells, cardiac cells, and smooth muscle cells. K0.5, the half-maximal effect of the enantiomer (-)-cromakalim, is as low as 10 nM, whereas K0.5 for nicorandil is 100 nM. These two compounds appear to have a much higher affinity for nerve cells than for smooth muscle cells. Openers of sulfonylurea-sensitive K+ channels lead to inhibition of gamma-aminobutyric acid release. There is an excellent relationship between potency to activate 86Rb+ efflux and potency to inhibit neurotransmitter release.
25
Michel Fosset, Jan R. de Weille, R D Green et al. · Journal of Biological Chemistry · 1988 · 292 citations · Full text
Medicine, Biochemistry, Pharmacology +17